Terminated Collaboration Product definition

Terminated Collaboration Product means a Terminated Development Collaboration Product or a Terminated Commercialized Collaboration Product.
Sample 1Sample 2Sample 3
Terminated Collaboration Product shall have the meaning set -------------------------------- forth in Section 16.12.
Sample 1Sample 2Sample 3
Terminated Collaboration Product means the same combination of drugs that would otherwise have been referred to as the Collaboration Product if no termination had occurred. If a Party elects to exercise its right to terminate this Agreement under this Section 10.2(d) then the other Party shall deliver to the terminating Party within 30 days after receipt of such written notice a [*]. Within fifteen (15) days after receipt of such accounting the terminating Party shall pay to the non-terminating Party a termination fee equal to [*]. Notwithstanding any other provisions of this Agreement, and in consideration of the payment of the termination fee, upon the exercise of the right of a Party to terminate this Agreement with respect to a Collaboration Product under this Section 10.2(d), the non-terminating Party shall not be entitled to utilize any of the terminating Party’s Technology to further develop the affected Collaboration Product. If CyDex is the terminating Party, then CyDex shall be prohibited from further developing, manufacturing or distributing the affected Terminated Collaboration Product for use with a hand-held inhalation device for [*]. If Aradigm is the terminating Party, then Aradigm shall be prohibited from further developing, manufacturing or distributing the affected Terminated Collaboration Product using Aqueous Formulations for [*] ([*]) years from the Collaboration Product Termination Date.
Sample 1

Examples of Terminated Collaboration Product in a sentence

  • In the event of termination of development of a particular Collaboration Product and an alternative Collaboration Product replaces such Terminated Collaboration Product then milestone payments for such replacement compound shall not be paid in respect of milestones already achieved by the Terminated Collaboration Product.

  • GSK shall, at its sole ------------------------------ expense, transfer to Adolor, or shall cause its designee(s) to transfer to Adolor, ownership of all regulatory filings made or filed for the Terminated Collaboration Product (to the extent that any are held in GSK's or such designee(s)'s name), if permitted by applicable Laws and regulations.

  • GSK shall, at its own expense, assign to Adolor the Adolor Product Trademarks which were used in connection with a Terminated Collaboration Product in respect of those Countries in the ROW in which GSK owns the Adolor Product Trademarks.

  • Inventory of the Terminated Collaboration Product not sold to Adolor or inventory not sold out by GSK shall be destroyed at GSK's sole cost and expense.

  • GSK shall, at its sole expense, ------------------- promptly transfer to Adolor copies of all data, reports, records and materials in its possession or control that relate to the Terminated Collaboration Product and return to Adolor, or destroy at Adolor's request, all relevant records and materials in its possession or control containing Confidential Information of Adolor (provided that GSK may keep one copy of such Confidential Information of Adolor for archival purposes only).

  • Adolor shall be entitled to decide, --------------------- within its reasonably exercised discretion, whether (i) GSK shall sell to Adolor or its designee at cost all remaining inventory of the Terminated Collaboration Product which are in good saleable condition, or (ii) GSK shall be entitled to sell out such remaining inventory under the conditions set forth in this Agreement, including all payment obligations, during a period of six (6) months after termination.

  • Subject to Section 16.12.6, all licenses -------------- granted by Adolor to GSK with respect to the applicable Terminated Collaboration Product in the applicable Terminated Collaboration Product in the applicable Country or Major Region under this Agreement shall be terminated.

  • GSK shall not be permitted to continue or re-initiate clinical Development of any GSK Compound that is both a Terminated Collaboration Product and a LABA in the Field for a period of [***]after the date of such termination.

  • GSK shall not be permitted to continue or re-initiate clinical Development of any GSK Compound that is both a Terminated Collaboration Product and a LABA in the Field for a period of [*] after the date of such termination.

  • Subject to Section 16.12.6, all licenses -------------- granted by Adolor to GSK with respect to the applicable Terminated Collaboration Product in the applicable ** under this Agreement shall be terminated.


More Definitions of Terminated Collaboration Product

Terminated Collaboration Product has the meaning given to such term in Section 13.6.1(d).
Sample 1

Related to Terminated Collaboration Product

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Licensed Compound means [***].

  • Terminated Product has the meaning set forth in Section 11.3.1.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Competing Product means [***].

  • Commercialized shall have corresponding meanings.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Licensed Territory means worldwide.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Research Program Term has the meaning set forth in Section 2.2.

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Combination Product means any combination of the Product with one (1) or more other active ingredients, products or services that is not the Product, where such products are sold either as a fixed dose/unit or as separate doses/units in a single package for a single price.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Royalty Term means, on a country-by-country basis, the period commencing on the First Commercial Sale of a Licensed Product in a country and ending on the latest of (a) ** thereafter, (b) expiration of the last-to-expire Valid Claim of a Licensed Patent that Covers the composition of matter of the Licensed Product in the country in which it is sold, or (c) the expiration of all Regulatory Exclusivity Rights with respect to such Licensed Product in the country in which it is sold.